Viemed Healthcare (VMD) Revenue Growth (1y) (2019 - 2026)
Viemed Healthcare (VMD) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 6.08% |
| 10 | Viemed Healthcare | 465.75 Mn | 455.99 Mn | 42.83 Mn | 27.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.54% |
| Dec 31, 2025 | 25.51% |
| Sep 30, 2025 | 23.98% |
| Jun 30, 2025 | 14.72% |
| Mar 31, 2025 | 16.87% |
| Dec 31, 2024 | 19.62% |
| Sep 30, 2024 | 17.41% |
| Jun 30, 2024 | 26.91% |
| Mar 31, 2024 | 27.90% |
| Dec 31, 2023 | 35.28% |
| Sep 30, 2023 | 38.15% |
| Jun 30, 2023 | 30.02% |
| Mar 31, 2023 | 22.64% |
| Dec 31, 2022 | 17.35% |
| Sep 30, 2022 | 22.11% |
| Jun 30, 2022 | 21.57% |
| Mar 31, 2022 | 13.51% |
| Dec 31, 2021 | 2.44% |
| Sep 30, 2021 | -12.44% |
| Jun 30, 2021 | -36.06% |